Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $688.54 million. The enterprise value is $539.29 million.

Market Cap	688.54M
Enterprise Value	539.29M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

ACRS has 139.66 million shares outstanding. The number of shares has increased by 37.77% in one year.

Current Share Class	139.66M
Shares Outstanding	139.66M
Shares Change (YoY)	+37.77%
Shares Change (QoQ)	+5.01%
Owned by Insiders (%)	2.26%
Owned by Institutions (%)	43.57%
Float	96.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	82.29
Forward PS	135.89
PB Ratio	5.76
P/TBV Ratio	6.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	64.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-38.97%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	8.50%
Revenue Per Employee	$114,616
Profits Per Employee	-$954,274
Employee Count	73
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +294.40% in the last 52 weeks. The beta is 0.78, so ACRS's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+294.40%
50-Day Moving Average	3.89
200-Day Moving Average	2.85
Relative Strength Index (RSI)	68.69
Average Volume (20 Days)	1,399,615

Short Selling Information

The latest short interest is 7.07 million, so 5.07% of the outstanding shares have been sold short.

Short Interest	7.07M
Short Previous Month	7.02M
Short % of Shares Out	5.07%
Short % of Float	7.32%
Short Ratio (days to cover)	4.34

Income Statement

In the last 12 months, ACRS had revenue of $8.37 million and -$69.66 million in losses. Loss per share was -$0.56.

Revenue	8.37M
Gross Profit	-51.83M
Operating Income	-78.48M
Pretax Income	-69.66M
Net Income	-69.66M
EBITDA	n/a
EBIT	-78.48M
Loss Per Share	-$0.56

Balance Sheet

The company has $90.75 million in cash and $2.12 million in debt, with a net cash position of $149.25 million or $1.07 per share.

Cash & Cash Equivalents	90.75M
Total Debt	2.12M
Net Cash	149.25M
Net Cash Per Share	$1.07
Equity (Book Value)	103.08M
Book Value Per Share	0.86
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-938.01%
Pretax Margin	-832.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.77%
Shareholder Yield	-37.77%
Earnings Yield	-10.12%
FCF Yield	n/a

Analyst Forecast

The average price target for ACRS is $11.33, which is 129.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.33
Price Target Difference	129.82%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	62.40%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a